Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marie Claire Okomo Assoumou is active.

Publication


Featured researches published by Marie Claire Okomo Assoumou.


The Pan African medical journal | 2014

Relationship between multiple drug resistance and biofilm formation in Staphylococcus aureus isolated from medical and non-medical personnel in Yaounde, Cameroon

Agnes Eyoh; Michel Toukam; Julius Atashili; Charles Fokunang; Hortense Kamga Gonsu; Emilia Lyonga; Henshaw Mandi; George Mondinde Ikomey; Bertha Mukwele; Martha Mesembe; Marie Claire Okomo Assoumou

Introduction Monitoring the prevalence of nasal carriage of multiple drug resistance (MDR) Staphylococcus aureus (SA) strains in hospital personnel is essential. These strains when transmitted from hospital personnel to patients with already weakened immune states or in-built medical devices, may limit the latters treatment options. This study aimed at assessing the potential exposure of patients to these MDR SA in a resource-limited hospital setting by assessing the prevalence and relationship between antimicrobial susceptibility and biofilm forming capacity of SA isolates from hospital personnel. Methods A total of 59 bacteria isolates phenotypically identified as Staphylococcus aureus obtained from medical (39) and non-medical personnel (20) in Yaounde were used in the study. Multiple drug resistance defined as resistance to four or more of twelve locally used antibiotics were determined by Kirby Bauer disc diffusion technique whereas quantification of biofilm production was by the microtitre plate method. Results Among the 59 SA isolates, the prevalence of MDR was 50.9%. Among medical personnel 48.7% had MDR as against 55.9% for non-medical personnel (p-value=0.648). The overall percentage of weak biofilm producers was 35.6%. Although the prevalence of weak biofilm formers was higher in isolates from non-medical personnel (40%) than medical personnel (33.3%) the difference was not statistically significant (p-value= 0.246). Slightly less than half (42.9%) of the weak biofilm producers were MDR. Conclusion Considering the high rates of MDR and that slightly less than half of biofilm formers were MDR, these trends need to be monitored regularly among hospital personnel in Yaounde.


BMC Research Notes | 2018

Chronic obstructive pulmonary disease (COPD) : neutrophils, macrophages and lymphocytes in patients with anterior tuberculosis compared to tobacco related COPD

Elise Guiedem; George Mondinde Ikomey; Céline Nguefeu Nkenfou; Pefura-Yone Eric Walter; Martha Mesembe; Novel N. Chegou; Graeme Brendon Jacobs; Marie Claire Okomo Assoumou

ObjectiveThe inflammatory profile of chronic obstructive pulmonary disease (COPD) related to tobacco is known in certain studies while that of the post tuberculosis form is not yet known. This study aimed to evaluate the levels of neutrophils, macrophages and lymphocytes cells in sputum of COPD patients with history of smoking or anterior tuberculosis. Enumeration of cells in samples was analyzed using standard microscopy.ResultsWe enrolled 92 participants, 46 (50%) were COPD subjects comprising 22 (47.83%) smokers and 24 (52.17%) with anterior tuberculosis while 46 (50%) healthy persons constituted the control group. The levels of neutrophils, lymphocytes and monocytes were statistically higher in COPD patients compared to the control group with p-values of 0.0001 respectively. Neutrophils levels were higher in COPD patients with history of tobacco than in COPD patients with anterior tuberculosis with a mean rate of 4.72 × 106/ml and 2.48 × 106/ml respectively (p = 0.04). The monocytes and lymphocytes levels were not statistically different between the two sub-groups of COPD patients with p-value of 0.052 and 0.91 respectively. Neutrophils are the only inflammatory cells that were significantly higher in COPD patients with history of smoking as compared to COPD patients with anterior tuberculosis.


Germs | 2017

Observed HIV drug resistance associated mutations amongst naïve immunocompetent children in Yaoundé, Cameroon

George Mondinde Ikomey; Marie Claire Okomo Assoumou; Josiah Otwoma Gichana; Duncan Njenda; Sello Given Mikasi; Martha Mesembe; Emilia Lyonga; Graeme Brendon Jacobs

Introduction The emergence of drug resistance mutations (DRMs) has been a major threat for successful lifelong combination antiretroviral therapy (cART), especially for HIV-vertically infected children within the context of the prevention of mother-to-child transmission (PMTCT). This study aimed to evaluate DRMs amongst immune competent treatment-naïve children in Cameroon. Methods A cross-sectional study was conducted between 2015 and 2016 amongst 55 proxy consented HIV-1 positive children, aged 9 months to 6 years. They were all immune competent, cART naïve and with unknown history of PMTCT. CD4 cell counts and genotypic drug resistance testing were performed using standard methods. Results Levels of DRMs to protease (PR) inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs) and non-NRTIs were 27.6%, 3.7% and 40.7%, respectively. Only minor DRMs were observed for PR. The observed mutations for NRTI were K65R, T215I and K219E (33.0% each) and for NNRTI: V106M, Y181C and Y188H (6.0% each). Only minor accessory mutations were found in the integrase (IN) region. Conclusion Despite widely available cART we still observe naïve HIV children, especially from the rural communities. We observe that a proportion of study participants had HIV-1 drug resistance associated mutations (RAMs). Data generated could help strengthen the current PMTCT programmes within the country. There is a need to upscale approaches for drug resistance testing for children in Cameroon and many other resource-limited settings.


Science Journal of Public Health | 2016

Evidence of Co and Triple Infections of Hepatitis B and C Amongst HIV Infected Pregnant Women in Buea, Cameroon

George Mondinde Ikomey; Graeme Brendon Jacobs; Becky Tanjong; Martha Mesembe; Agnes Eyoh; Emilia Lyonga; Ebot Mfoataw; Rose Ngoh; Cynthia Raissa Tamandjou; Greg Ikomey; Marie Claire Okomo Assoumou


Tobacco Induced Diseases | 2018

Some cellular inflammatory characteristics in patients with chronic obstructive pulmonary disease (COPD) with anterior tuberculosis compared to tobacco related COPD

Elise Guiedem; Marie Claire Okomo Assoumou; George Ikomey Mondinde; Eric Walter Pefura Yone; Céline Nkenfou


HEALTH SCIENCES AND DISEASES | 2017

Effects of Storage: Whole Blood Specimens for CD4-T Lymphocytes Determination in Yaoundé, Cameroon

Marie Claire Okomo Assoumou; George Nguefack; Graeme Brendon Jacobs; Elise Guidem; Gilbert Ndeh Doh; Martha Mesembe; Emilia Lyonga; George Mondinde Ikomey


HEALTH SCIENCES AND DISEASES | 2017

Oncogenic Human Papillomavirus Genotypes 16 and 18 Prevalence Among Women with Normal Cervical Cytology and Neoplasia in Cameroon: A Systematic Review

Gilbert Ndeh Doh; George Mondinde Ikomey; Duncan Njenda; Josiah Otwoma Gichana; Mary Grace Katusiime; Valantine Ngum Ndze; Michelle Zeier; Martha Mesembe; Charles Fokunang; Marie Claire Okomo Assoumou; Pierre-Marie Tebeu; Paul Adrien Atangana; Graeme Brendon Jacobs


HEALTH SCIENCES AND DISEASES | 2013

Antibiotiques et Résistance Bactérienne : Mieux Vaut s’y Intéresser dès Maintenant …

Samuel Nko'o Amvene; Marie Claire Okomo Assoumou


HEALTH SCIENCES AND DISEASES | 2013

ANTIBIOTICS SUSCEPTIBILITY PROFILE OF STAPHYLOCOCCUS AUREUS ISOLATED FROM THE ANTERIOR NARES OF HOSPITAL PERSONNEL IN YAOUNDE, CAMEROON

Agnes Eyoh; Michel Toukam; Hortense Kamga Gonsu; Charles Fokunang; Emilia Lyonga; George Mondinde Ikomey; Bertha Mukwele; Martha Mesembe; Nguefack Tsague; Henshaw Mandi; Marie Claire Okomo Assoumou


HEALTH SCIENCES AND DISEASES | 2013

IMMUNOGLOBULIN A (IGA) LEVELS IN HEALTHY BLOOD DONORS IN YAOUNDE, CAMEROON

Marie Claire Okomo Assoumou; E Akongnwi Mugyia; A Esiene; G Ikomey Mondinde; Martha Mesembe; Dieudonné Adiogo; Julius Atashili; Emilia Lyonga; Agnes Eyoh; Peter Ndumbe

Collaboration


Dive into the Marie Claire Okomo Assoumou's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Agnes Eyoh

University of Yaoundé

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A Esiene

University of Yaoundé

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge